An empirical analysis of overall survival in drug approvals by the US FDA (2006–2023)

by Josh Elbaz, Alyson Haslam, Vinay Prasad
Published 2024-04-01

Peginterferon lambda for the treatment of hospitalized patients with mild COVID-19: A pilot phase 2 randomized placebo-controlled trial

by Myung-Ho Kim, Myung-Ho Kim, Josh Elbaz, Josh Elbaz, Nikolaus Jilg, Nikolaus Jilg, Jenna L. Gustafson, Jenna L. Gustafson, Min Xu, Min Xu, Dilara Hatipoglu, Eric Nohelty, Eric Nohelty, Arthur Y. Kim, Arthur Y. Kim, Raymond T. Chung, Raymond T. Chung
Published 2023-02-01